< Back to all Breaking News
RVVTF
5/26/2022 10:05am
Revive Therapeutics provides update on Phase 3 trial for bucillamine in COVID-19
Don't miss out!
We read the Wall Street research, SEC filings and press releases so you don't have to.
Sign up for our 14-day free trial to read this story.